Free Trial

Envista (NVST) Competitors

Envista logo
$20.37 +0.11 (+0.54%)
(As of 11/20/2024 ET)

NVST vs. SOLV, SNN, PEN, GKOS, BLCO, INSP, PRCT, AXNX, NARI, and LIVN

Should you be buying Envista stock or one of its competitors? The main competitors of Envista include Solventum (SOLV), Smith & Nephew (SNN), Penumbra (PEN), Glaukos (GKOS), Bausch + Lomb (BLCO), Inspire Medical Systems (INSP), PROCEPT BioRobotics (PRCT), Axonics (AXNX), Inari Medical (NARI), and LivaNova (LIVN). These companies are all part of the "medical equipment" industry.

Envista vs.

Solventum (NYSE:SOLV) and Envista (NYSE:NVST) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, profitability, institutional ownership, media sentiment, dividends, community ranking, earnings, valuation and risk.

Solventum currently has a consensus price target of $68.00, suggesting a potential downside of 0.57%. Envista has a consensus price target of $20.71, suggesting a potential upside of 1.66%. Given Envista's stronger consensus rating and higher possible upside, analysts plainly believe Envista is more favorable than Solventum.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Solventum
1 Sell rating(s)
8 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
Envista
1 Sell rating(s)
11 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.13

Solventum has a net margin of 0.00% compared to Envista's net margin of -53.42%. Envista's return on equity of 3.76% beat Solventum's return on equity.

Company Net Margins Return on Equity Return on Assets
SolventumN/A N/A N/A
Envista -53.42%3.76%2.24%

In the previous week, Solventum had 6 more articles in the media than Envista. MarketBeat recorded 13 mentions for Solventum and 7 mentions for Envista. Envista's average media sentiment score of 0.89 beat Solventum's score of 0.88 indicating that Envista is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Solventum
7 Very Positive mention(s)
0 Positive mention(s)
5 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
Envista
3 Very Positive mention(s)
0 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Solventum has higher earnings, but lower revenue than Envista.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SolventumN/AN/AN/AN/AN/A
Envista$2.57B1.37-$100.20M-$7.77-2.62

Envista received 33 more outperform votes than Solventum when rated by MarketBeat users. Likewise, 38.20% of users gave Envista an outperform vote while only 5.88% of users gave Solventum an outperform vote.

CompanyUnderperformOutperform
SolventumOutperform Votes
1
5.88%
Underperform Votes
16
94.12%
EnvistaOutperform Votes
34
38.20%
Underperform Votes
55
61.80%

Summary

Envista beats Solventum on 9 of the 11 factors compared between the two stocks.

Get Envista News Delivered to You Automatically

Sign up to receive the latest news and ratings for NVST and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

NVST vs. The Competition

MetricEnvistaDental equipment & supplies IndustryMedical SectorNYSE Exchange
Market Cap$3.51B$3.47B$5.03B$19.87B
Dividend YieldN/A1.85%5.16%3.52%
P/E Ratio-2.6237.26135.4142.95
Price / Sales1.371.951,160.9719.16
Price / Cash8.085.3533.5317.86
Price / Book0.842.084.675.52
Net Income-$100.20M-$33.08M$119.07M$986.45M
7 Day Performance1.44%3.95%-1.83%0.45%
1 Month Performance9.69%-7.46%-3.60%1.05%
1 Year Performance-14.95%134.51%31.66%24.67%

Envista Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NVST
Envista
3.6426 of 5 stars
$20.37
+0.5%
$20.71
+1.7%
-14.3%$3.49B$2.57B-2.6212,800
SOLV
Solventum
1.804 of 5 stars
$68.39
+2.0%
$68.00
-0.6%
N/A$11.58BN/A0.0022,000
SNN
Smith & Nephew
2.1198 of 5 stars
$25.22
-1.2%
N/A-1.4%$11.15B$5.55B0.0018,452
PEN
Penumbra
4.3167 of 5 stars
$239.20
+0.9%
$227.92
-4.7%
+1.6%$9.18B$1.16B278.144,200Analyst Forecast
Insider Trade
GKOS
Glaukos
3.8428 of 5 stars
$141.44
-1.9%
$134.55
-4.9%
+121.3%$7.80B$360.35M-46.83780Positive News
BLCO
Bausch + Lomb
2.7887 of 5 stars
$19.39
-0.8%
$20.91
+7.8%
+23.2%$6.88B$4.15B0.0013,300
INSP
Inspire Medical Systems
4.9104 of 5 stars
$184.88
+5.0%
$233.58
+26.3%
+29.2%$5.28B$624.80M172.781,011Analyst Upgrade
Positive News
Gap Up
PRCT
PROCEPT BioRobotics
1.5867 of 5 stars
$92.70
-0.9%
$89.50
-3.5%
+180.7%$4.88B$136.19M0.00626
AXNX
Axonics
3.2587 of 5 stars
$70.98
flat
$71.00
+0.0%
N/A$3.63B$366.38M-591.45610News Coverage
NARI
Inari Medical
3.2625 of 5 stars
$49.00
-3.9%
$58.89
+20.2%
-15.9%$2.98B$493.63M0.001,300Insider Trade
Positive News
LIVN
LivaNova
4.1794 of 5 stars
$50.05
-2.6%
$69.17
+38.2%
+6.8%$2.79B$1.15B119.172,900

Related Companies and Tools


This page (NYSE:NVST) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners